Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anisindione

Copy Product Info
🥰Excellent
Catalog No. T14291Cas No. 117-37-3

Anisindione is a synthetic anticoagulant and an indanedione derivative. It prevents the formation of active procoagulation factors II, VII, IX, and X, as well as the anticoagulant proteins C and S, in the liver by inhibiting the vitamin K–mediated gamma-carboxylation of precursor proteins.

Anisindione

Anisindione

Copy Product Info
🥰Excellent
Purity: 98.25%
Catalog No. T14291Cas No. 117-37-3
Anisindione is a synthetic anticoagulant and an indanedione derivative. It prevents the formation of active procoagulation factors II, VII, IX, and X, as well as the anticoagulant proteins C and S, in the liver by inhibiting the vitamin K–mediated gamma-carboxylation of precursor proteins.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
50 mg$33In StockIn Stock
1 mL x 10 mM (in DMSO)$50In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.25%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Anisindione AI Summary
Anisindione exhibits a wide array of bioactivities spanning various biological systems and assays. It inhibits the binding of Batrachotoxinin [3H]BTX-B to high-affinity sites on voltage-dependent sodium channels in guinea pig cerebral cortex with minimal inhibition at higher concentrations. In RBL-1 cells, it inhibits 5-lipoxygenase activity with an IC50 value of 9100.0 nM. In in vivo studies on CF1 male mice and Sprague-Dawley rats, Anisindione demonstrates hypolipidemic activity by reducing serum cholesterol and triglyceride levels, and affecting key liver enzymes involved in lipid metabolism. Furthermore, it exhibits diverse bioactivity such as modulating miRNAs, enhancing SMN2 splice variant expression, inhibiting Tau fibril formation, and showing cytotoxicity toward p53-mutant cancer cells. It acts on various receptors and enzymes, indicating potential effects on neurotransmitter systems, inhibiting viral entries like Ebola and Hepatitis C Virus, and inhibiting Histone Lysine Methyltransferase G9a. In terms of antiviral properties, Anisindione shows activity against SARS-CoV-2, inhibiting virus-induced cytotoxicity in Caco-2 and Vero E6 cells, despite demonstrating relatively low inhibition percentages and high IC50 values in some assays. It also inhibits SARS-CoV-2 3CL-Pro protease by 9.717% at 20µM concentration. Biochemically, Anisindione impairs oxidative phosphorylation in rat liver mitochondria, significantly inhibits sodium fluorescein uptake in OATP1B1/1B3-transfected CHO cells, shows potential as an HDAC6 inhibitor with high inhibition rates, and affects several markers related to liver and kidney function, as well as blood chemistry parameters. Thus, Anisindione holds promise for various therapeutic and biochemical applications due to its multifaceted bioactivity..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Anisindione is a synthetic anticoagulant and an indanedione derivative. It prevents the formation of active procoagulation factors II, VII, IX, and X, as well as the anticoagulant proteins C and S, in the liver by inhibiting the vitamin K–mediated gamma-carboxylation of precursor proteins.
Chemical Properties
Molecular Weight252.26
FormulaC16H12O3
Cas No.117-37-3
SmilesCOc1ccc(cc1)C1C(=O)c2ccccc2C1=O
Relative Density.1.1824 g/cm3 (Estimated)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 50 mg/mL (198.21 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (7.93 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.9642 mL19.8208 mL39.6416 mL198.2082 mL
5 mM0.7928 mL3.9642 mL7.9283 mL39.6416 mL
10 mM0.3964 mL1.9821 mL3.9642 mL19.8208 mL
20 mM0.1982 mL0.9910 mL1.9821 mL9.9104 mL
50 mM0.0793 mL0.3964 mL0.7928 mL3.9642 mL
100 mM0.0396 mL0.1982 mL0.3964 mL1.9821 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Anisindione | purchase Anisindione | Anisindione cost | order Anisindione | Anisindione chemical structure | Anisindione formula | Anisindione molecular weight